Data from a phase 1b/2a trial have raised doubts about whether Wave Life Sciences’ Huntington’s disease drug can compete with Roche and Ionis’ rival candidate. The results wiped 50% off Wave’s share ...
Controlling submerged and partially submerged bodies, whose motions are coupled hydrodynamically, is one of our primary research areas. An array of wave energy converters (WECs) is one example where ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results